<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(5)</volume><submitter>Lizzadro L</submitter><funding>Saxony-Anhalt</funding><pubmed_abstract>The synthesis of a novel disorazole C&lt;sub>1&lt;/sub> analogue is described, and its biological activity as a cytotoxic compound is reported. Based on our convergent and flexible route to the disorazole core, we wish to report a robust strategy to synthesize a non-symmetrical disorazole in which we couple one half of the molecule containing the naturally occurring oxazole heterocycle and the second half of the disorazole macrocycle containing a thiazole heterocycle. This resulted in a very unusual non-symmetrical disorazole C&lt;sub>1&lt;/sub> analogue containing two different heterocycles, and its biological activity was studied. This provided exciting information about SAR (structure-activity-relationship) for this highly potent class of antitumor compounds.</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>1123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10934378</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis of a Non-Symmetrical Disorazole C&lt;sub>1&lt;/sub>-Analogue and Its Biological Activity.</pubmed_title><pmcid>PMC10934378</pmcid><pubmed_authors>Schinzer D</pubmed_authors><pubmed_authors>Stadler M</pubmed_authors><pubmed_authors>Spieß O</pubmed_authors><pubmed_authors>Lizzadro L</pubmed_authors><pubmed_authors>Reinecke S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of a Non-Symmetrical Disorazole C&lt;sub>1&lt;/sub>-Analogue and Its Biological Activity.</name><description>The synthesis of a novel disorazole C&lt;sub>1&lt;/sub> analogue is described, and its biological activity as a cytotoxic compound is reported. Based on our convergent and flexible route to the disorazole core, we wish to report a robust strategy to synthesize a non-symmetrical disorazole in which we couple one half of the molecule containing the naturally occurring oxazole heterocycle and the second half of the disorazole macrocycle containing a thiazole heterocycle. This resulted in a very unusual non-symmetrical disorazole C&lt;sub>1&lt;/sub> analogue containing two different heterocycles, and its biological activity was studied. This provided exciting information about SAR (structure-activity-relationship) for this highly potent class of antitumor compounds.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T21:31:09.271Z</modification><creation>2025-04-04T21:31:09.271Z</creation></dates><accession>S-EPMC10934378</accession><cross_references><pubmed>38474635</pubmed><doi>10.3390/molecules29051123</doi></cross_references></HashMap>